GC
-
GDS prices $1.7bn HK secondary listing
Chinese data centre operator GDS Holdings has pocketed HK$12.9bn ($1.67bn) from its secondary offering on Hong Kong’s stock exchange.
08.15 AM -
Krafton picks underwriters for Korean IPO
Krafton, a popular South Korean video game developer, has mandated banks for its 2021 IPO.
07.45 AM -
RemeGen launches $514m Hong Kong listing
RemeGen, a Chinese biopharmaceutical company, has rolled out a Hong Kong IPO that could be worth up to HK$3.99bn ($514.5m).
05.45 AM -
Lufax hooks investors to $2.4bn US listing
Ping An Insurance-backed Lufax Holdings has covered its $2.36bn US listing. Global heavy-weight investors flocked to the long-awaited deal.
27 Oct 2020 -
JW Therapeutics closes IPO early
Chinese biotechnology firm JW (Cayman) Therapeutics is set to close the book for its Hong Kong IPO on Tuesday, a daily earlier than planned, according to a source familiar with the matter.
27 Oct 2020 -
Ant covers $34bn Hong Kong-Shanghai IPO
Chinese financial technology company Ant Group is set to raise $34.3bn from the world’s largest ever IPO, after covering the deal within minutes of launch.
27 Oct 2020 -
Fosun-backed Gland Pharma gets Sebi nod for Rp60bn IPO
Gland Pharma, a subsidiary of Shanghai Fosun Pharmaceutical Group, has won approval for its IPO from India’s securities regulator, according to a source close to the deal.
23 Oct 2020 -
Lufax launches roadshow for $2.36bn US IPO
Lufax Holdings, a personal finance services platform, has opened books for its offering of American depositary shares (ADS). It is aiming to raise up to $2.36bn.
23 Oct 2020 -
Ant comes closer to jumbo listing as investors vie for $35bn deal
China’s Ant Group kicked off marketing for its Hong Kong and Shanghai dual listing on Thursday, the last stage before launching a possible $35bn IPO, set to be the world’s largest to date. The combined offering is already more than a third covered by onshore investors, with global buyers lining up for the rest. Addison Gong and Jonathan Breen report.
22 Oct 2020 -
JW Therapeutics opens $300m Hong Kong IPO
JW (Cayman) Therapeutics set its IPO in motion on Thursday, opening the order book for the up to HK$2.3bn ($300m) deal.
22 Oct 2020
